LSE · Healthcare

Oxford Nanopore Technologies Ltd (ONT)

Biotechnology

Oxford Nanopore Technologies Ltd (ONT) is listed on LSE in the Healthcare sector. Industry: Biotechnology. As of 2026-05-19, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ONT

P/E ratio

25.00

Oxford Nanopore Technologies Ltd (ONT) — FAQ

What is ONT's P/E ratio?

The price-to-earnings (P/E) ratio for Oxford Nanopore Technologies Ltd (ONT) is 25.00 (data as of 2026-05-19).

Does Oxford Nanopore Technologies Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Oxford Nanopore Technologies Ltd (ONT). Check the MyAverix Finance app for the latest dividend data.

What sector is Oxford Nanopore Technologies Ltd in?

Oxford Nanopore Technologies Ltd (ONT) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ONT listed on?

ONT is listed on LSE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)